FDA Drug recall D-0744-2026
Cyclophosphamide for Injection, USP, 2 gram/vial, One Single-Dose Vial, Rx only, Manufactured for: Long Grove Pharmaceuticals, LLC, Rosemon…
- FDA Drug
- Class I
- ongoing
- Published 2026-08-12
On 2026-08-12 the FDA classified a Class I recall of Cyclophosphamide for Injection, USP, 2 gram/vial, One Single-Dose Vial, Rx only, Manufactured for: Long Grove Pharmaceuticals, LLC, Rosemon… by Sunny Pharmtech, citing presence of Particulate Matter; identified as stainless steel.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-0744-2026 |
| Classification | Class I |
| Status | ongoing |
| Initiated | 2026-07-17 |
| Published | 2026-08-12 |
| Last updated | 2026-09-13 11:52 UTC |
| Company | Sunny Pharmtech |
| Distribution | US |
Product
Cyclophosphamide for Injection, USP, 2 gram/vial, One Single-Dose Vial, Rx only, Manufactured for: Long Grove Pharmaceuticals, LLC, Rosemont, IL 60018. Manufactured in Taiwan, NDC 81298-8114-1
Reason
Presence of Particulate Matter; identified as stainless steel
Identifiers
| code_info | Lot # V24010V1, Exp 3/31/2027 |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: ongoing.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0744-2026%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.